Fetalix has launched a new visual identity developed in collaboration with Vogal, a creative studio led by Ana Pessanha, Paulo Sá, Daniel Teixeira, and Lucas Aranha. The rebranding reflects the company’s evolution in regenerative medicine and its continued development as a biotechnology startup.
The new branding aligns Fetalix’s visual communication with its scientific and strategic focus, supporting clearer representation of its work in regenerative solutions for intervertebral disc degeneration and low back pain.
As part of this update, the company has also launched a redesigned website to improve communication with partners and stakeholders. Together, these changes strengthen how Fetalix presents its mission and technological focus to the scientific and business communities.
October 15, 2024
